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Abstract— A new method using electrochemical oxidation and/or OSO4 oxidation has been 
exploited for the stereoselective synthesis of 2,3,6-trihydroxylated 5S-piperidine derivatives. 
The electrochemical method was successively used for the conversion of N-protected 
piperidines to N-protected 1-methoxypiperidines and for the conversion of 
2,3-didehydro-1-methoxypiperidine derivatives to 2,3-trans-1,2,3-triacetoxypiperidine 
derivatives. These triacetates were easily transformed into 2S,3S,6-triacetoxy-5S-methyl-
piperidine and 2R,3R,6-triacetoxy-5S-methylpiperidine. In addition, 2,3-cis-dihydroxylation 
of 2,3-didehydro-1-methoxypiperidine derivatives with OsO4 afforded 2R,3S,6-tri-
acetoxy-5S-methylpiperidine and 2S,3R,6-triacetoxy-5S-methylpiperidine. 
 
1. Introduction 
   Polyhydroxylated 5S-methylpiperidines 1, a class of piperidine iminosugars, have attracted 
great interest due to their biological properties.1,2 Some of them are potential inhibitors of 
glycosidases and glycoprotein-processing enzymes. Now they are widely investigated as 
candidates for drugs to treat a variety of carbohydrate-mediated diseases such as diabetes, 
viral infections including HIV, and cancer metastasis. The inhibitory activities depend on the 
configuration and the number of hydroxyl groups. Among 1, 2,3,6-trihydroxy-5S-methyl-
piperidines 2 are noteworthy since recently it has been reported that 2R,3S,6-tri-
hydroxy-5S-methylpiperidine (2a), one of the possible stereoisomers 2a-d (Fig. 2), has high 
inhibitory activities toward glycosidases. However, there has not been any convenient 
synthetic method for 2a-d.3,4 We have exploited a facile method for the stereoselective 
synthesis of 2a-d, and preliminarily reported the synthesis of 2b,c using electrochemical 
2,3-trans-diacetoxylation.5 This paper describes the synthesis for 2b,c as well as those for 













































Figure 2. Stereoisomers 2a-d of 2,3,6-trihydroxy-5S-methylpiperidines 2. 
 
2. Result and discussion 
2.1 Electrochemical 2,3-trans-diacetoxylation  
   Our strategy to this end is based on preparation of triacetate 6, a precursor of 2, from 
5S-acetoxymethylpiperidine derivative 3 by electrochemical oxidation; electrochemical 
1-methoxylation of 3 and electrochemical triacetoxylation of 5S-acetoxymethyl-2,3-di-
dehydro-1-methoxypiperidine derivative 4 (Eq. 1).  





















The first key electrochemical reaction in the scheme has already been used in the 
transformation of N-methoxycarbonylpiperidine 7a to 2,3-didehydro-1-methoxypiperidine 
10a. The transformation consisted of electrochemical oxidation of 7a to afford 
1-methoxypiperidine 8a,6 elimination of MeOH from 8a to 1,2-didehydropiperidine 9a,7 
which then underwent bromine oxidation8 followed by base-induced dehydrobromination to 
form 2,3-didehydro-1-methoxypiperidine 10a (Eq. 2).9 The other 2,3-didehydro 
-1-methoxypiperidines 10b-d were similarly prepared from 7b-d.  











































With 10a-d in hand, we examined the second key electrochemical triacetoxylation of 
10a-d, which was carried out in acetic acid containing potassium acetate (Eq. 3).10 As 
expected, the oxidation gave triacetoxylated products 11a-d, though their stereochemistry was 
not determined at this stage. Then we achieved the reductive elimination of 1-acetoxyl group 
of 11a-d by Et3SiH to afford 2,3-diacetoxypiperidines 12a-d. The yields of 11a-d and 12a-d 
























Electrochemical oxidation of 10a-d followed by reduction of 11a-d with Et3SiH 
Entry 10a-d 
R 
Yield (%) trans:cis 
(12a-d) 11a-d 12a-d 
1 OMe 81 84 70:30 
2 OCH2Ph 54 82 58:42 
3 H 78 65 66:34 
4 Ph 80 45 54:46 
 
The stereochemistry (trans/cis) of 12a-d was a little bit dependent on R (70/30~54/46).11 
We then, tried the preparation of 4 from easily available L-lysine derivative 1312 instead of 
expensive L-pipecolic acid derivative 3 through 14 and 1513 to obtain 4 in a similar way to 
transformation of 7 to 10. The result is shown in Scheme 1. Electrochemical oxidation of 4 
under conditions similar to the oxidation of 10 to 11 afforded tetraacetoxylated piperidine 5, 
of which reduction with Et3SiH gave 2,3,6-triacetoxy-5S-methylpiperidine 6 as a mixture of 





















































Scheme 1. Preparation of 62S,S, 5S starting from 3 or 13. 
 
Fortunately, the main product 62S,S,5S crystallized, and the absolute stereochemistry was 





Figure 3. Ortep drawing of 62S,S,5S. 
 
On the other hand, electrochemical oxidation of bicyclic carbamate 19, which was 
prepared from L-pipecolic acid derivative 16 or from L-lysine derivative 22 through 1713 and 
18,15 followed by reduction of the oxidation product 20 (70% yield) with Et3SiH gave a single 
stereoisomer 21 (Scheme 2), of which absolute stereochemistry was also determined by its 




























































Figure 4. Ortep drawing of 212R,3R,5S. 
 
  The reaction mechanism for electrochemical triacetoxylation is tentatively proposed as 
follows (Scheme 3). Since it was found that 10a was immediately converted to 
3-acetoxy-1,2-didehydropiperidine 239i under the reaction conditions, oxidation of 23 may be 
responsible for the formation of 11a by EC mechanism through dication A or by ECEC 
mechanism through cation radical B, radical C, and cation D.10 Similarly, electrochemical 
triacetoxylation of 4 and 19 may proceed via 3-acetoxypiperidine derivatives 24 and 25, 
respectively (Fig. 5). Since cis-isomer 24 was thermodynamically more stable than its 
trans-isomer 24’, 24 should be stereospecifically formed. On the other hand, treatment of 19 
with acetic acid could generate a cationic species E, in which the endo side might be more 












































































Figure 5. Plausible intermediary species for electrochemical oxidation of 4 and 19 in AcOH. 
 
The oxidation potentials of some 1,2-didehydro- and 2,3-didehydro-piperidine derivatives 
shown in Table 2 support this proposed mechanism. 
 
Table 2.  
Oxidation potential of didehydropiperidine derivatives 
Entry Compound  Oxidation 
Potential 
(V)a 









































a V vs Ag/AgNO3, 0.1 M Et4NClO4/MeCN, 100mV/s. 
 
A predominant formation of 52S,3S,5S and 202R,3R,5S may be explained by an ECEC 
mechanism shown in Scheme 4. As for 3-acetoxy-1,2-didehydropiperidine intermediate 24, it 
is possible that the plausible intermediary species could be electrochemically generated cation 
radical F.10b,16 Therefore, the observed high diastereoselectivity in electrochemical oxidation 
of 243S,5S can be explained as follows: acetate ion attack on the cationic intermediate F is 
easier from the axial direction than the equatorial direction to produce 52S,3S,5S through the 
radical intermediate G. The stereoselectivity is explainable in terms of participating effect of 
3-acetoxyl group or thermodynamic control of the product. On the other hand, in the case of 
electrochemical oxidation of 253R,5S, acetate ion attack to cation radical H is easier from the 
equatorial direction than the axial direction to produce 202R,3R,5S through the radical 
intermediate I. 
The less stereoselective triacetoxylation of 10a-d may be due to a conformational 






























































Scheme 4. Plausible mechanism for electrochemical 2,3-trans-acetoxylation of 24 and 25. 
 
2.2 cis-Selective 2,3-dihydroxylation with OsO4  
To prepare 2,3-cis-dihydroxylated compounds 2a and 2d, oxidation of 4 or 19 with OsO4 





































Scheme 5. Strategy for preparation of 2a and 2d. 
 
First, we investigated the OsO4 oxidation of 10a. Compound 10a was oxidized with 
catalytic OsO4 and 1.5 equiv of NMO followed by acetylation with acetic anhydride and 
pyridine to produce 2,3,4-triacetoxypiperidine 11a in 71% yield. Compound 11a was easily 





4% aq. OsO4 
(0.006 equiv)



















Encouraged by this result, we continuously tried to apply the same conditions to 
5S-acetoxymethylpiperidine derivatives 4 (Scheme 6). As expected, the OsO4 oxidation and 
subsequent acetylation proceeded smoothly, but the reaction product was a mixture of 
2,3-diacetoxy-5S-acetoxymethyl-1-methoxy-N-methoxycarbonylpiperidine 29a  and 
1,2,3-triacetoxy-5S-acetoxymethyl-N-methoxycarbonylpiperidine 29b. Without purification of 
the mixture, reduction with Et3SiH was carried out to provide only one product, 
2,3-diacetoxy-5S-acetoxymethyl-N-methoxycarbonylpiperidine 27. Since 27 did not 
crystallize, we tried to prepare its tosylated derivatives to determine absolute stereochemistry 
































Scheme 6. Preparation of 27. 
 
The OsO4 oxidation of 4 and successive reduction with Et3SiH gave 2,3-dihydroxylated 
derivative 30 as a single diastereomer (Scheme 7). Then, compound 30 was treated with tosyl 
chloride to afford crystal 2,3-ditosyloxylated derivative 31. The X-ray analysis of compound 



















 Et3N (1.2 equiv)
 DMAP (5.0 equiv)
OsO4 (0.006 equiv)
NMO (1.5 equiv) 
H2O/acetone










Figure 6. Ortep drawing of 312S,3R,5S. 
 
Next, the OsO4 oxidation of bicyclic carbamate 19 and successive acetylation with 
Ac2O-pyridine was examined to give 1-methoxy-2,3-diacetoxylated compound 32. In this 
case, 1-methoxy group remained unchanged in this reaction condition. Finally, compound 32 
was reduced by Et3SiH to afford 2,3-diacetoxylated bicyclic carbamate 28 as a single 
diastereomer (Eq. 5). The absolute stereoconfiguration of 28 was determined by X-ray 
analysis to be 2R,3S,5S (Fig. 7).14    
 
Et3SiH (5.0 equiv)














19 32, 85% 282R,3S,5S
     NMO (1.5 equiv)









Figure 7. Ortep drawing of 282R,3S,5S. 
 
The observed high diastereoselectivity by the OsO4 oxidation in this case can be explained by 
anomeric effect of 1-methoxyl group. That is, since the methoxyl group is mainly located at 
the axial position, it is difficult for OsO4 to get close to 19 from down side (approach B), 
while OsO4 can easily get close to 19 from the upper side (approach A) (Scheme 8). 
Accordingly, the OsO4 oxidation of 19 and successive reduction exclusively afford 





























Scheme 8. Effect of methoxyl group at the 1-position of 19. 
 
Next, bicyclic carbamate 33, which has no 1-methoxyl group, was examined. OsO4 
oxidation of 33 followed by acetylation afforded a mixture of 2R,3S-isomer 282R,3S,5S and 
2S,3R-isomer 282S,3R,5S, whose ratio was 24:76 (Eq. 6). This contrasting result for 33 and 19 
supports our proposed stereochemical course shown in Scheme 8. The result can represent the 



























24  :  76




In summary, the stereoselective formal syntheses of 2,3,6-trihydroxylated 5S-methyl-
piperidines 2a-d from L-lysine and L-pipecolic acid has been accomplished by using tandem 
electrochemical oxidation or OsO4 oxidation. 
 
4. Experimental Section 
4.1. General  
Electrochemical reactions were carried out using DC Power Supply (GP 0502) of 
Takasago Seisakusho, Inc. 1H NMR spectra were measured on a Varian Gemini 300 
spectrometer with TMS as an internal standard. IR spectra were obtained on a Shimadzu 
FTIR-8100A. Mass spectra were obtained on a JEOL JMS-DX 303 instrument. HPLC 
analyses were achieved by using a LC-10AT VP and a SPD-10A VP of Shimadzu Seisakusho, 
Inc. Specific rotations were measured with JASCO DIP-1000. Melting points are uncorrected. 
Elemental analyses were carried out at the Center for Instrumental Analysis, Nagasaki 
University. 
All reagents and solvents were used as supplied without further purification. 
 
4.2. Measurement of oxidation potentials 
   BAS CV-50W was used as a voltametric analyzer. A solution of substrate (0.1 mmol) in 
MeCN (10 mL) containing 0.1 M Et4NBF4 was measured. Reference electrode was 
Ag/AgNO3 in saturated aqueous KCl, a working electrode was a glassy carbon, and a counter 
electrode was a platinum wire. Scan rate was 100 mV/s.  
 
4.3. Preparation of 2,3-didehydro-1-methoxy-N-acylpiperidines 10a-d 
Transformations of 1-acylpiperidines 7a-d to 2,3-didehydro-1-methoxy-N-acylpiperidines 
10a-d were carried out according to our reported method.9 Compounds 8a,6a 8b,6c 8c,6b 8d,9c 
9a,7b 9b,7d 9c,7a 9d,7c 10a,9b and 10d9d are known. 
 
The characterization data for unknown compounds 10b and 10c are described below. 
N-Benzyloxycarbonyl-2,3-didehydro-1-methoxypiperidine (10b): 1H-NMR (CDCl3)  
1.92-2.05 (m, 1H), 2.10-2.30 (m, 1H), 3.05-3.25 (m, 1H), 3.29 and 3.39 (2s, 3H), 4.02-4.25 
(m, 1H), 5.12-5.26 (m, 2H), 5.40-5.55 (m, 1H), 5.70-5.84 (m, 1H), 5.95-6.06 (m, 1H), 7.36 (s, 
5H); IR (neat) 3038, 2936, 1713, 1655, 1428, 1200, 1082, 982, 698 cm1; HRMS (EI) m/z 
Calcd for C14H17NO3 (M
+): 247.1208. Found: 247.1181. 
 
2,3-Didehydro-N-formyl-1-methoxypiperidine (10c): 1H-NMR (CDCl3)  2.02-2.35 (m, 
2H), 2.98 (td, J = 13.1 and 6.0 Hz, 2/3H), 3.30 and 3.39 (2s, 2H and 1H), 3.45-3.52 (m, 2/3H), 
4.35 (dd, J = 13.5 and 6.4 Hz, 2/3H), 4.75 and 5.63 (2d, J = 3.0 and 3.0 Hz, 2/3H and 1/3H), 
5.78-5.88 (m, 1H), 5.92-6.10 (m, 1H), 8.26 and 8.29 (2s, 1/3H and 2/3H); IR (neat) 3567, 
2938, 1692, 1655, 1433, 1084, 957, 669 cm1; HRMS (EI) m/z Calcd for C7H11NO2 (M
+): 
141.0790. Found: 141.0770. 
 
Preparation of optically active 2,3-didehydro-1-methoxy-N-methoxycarbonylpiperidine 
(4) 
Compound 4 was prepared from L-lysine derivative 13 or L-pipecolic acid derivative 3 by 
our reported method.12b Compound 14 was transformed into compound 15 without 
purification. The characterization data for compounds 3, 4, 13, and 15 are described below. 
 
5S-Acetoxymethyl-N-methoxycarbonylpiperidine (3): []28D –45.6 (c 1.1, CHCl3); 
1H-NMR (CDCl3)  1.34-1.55 (m, 2H), 1.58-1.74 (m, 4H), 2.04 (s, 3H), 2.88 (t, J = 12.9 Hz, 
1H), 3.69 (s, 3H), 4.00-4.10 (m, 1H), 4.15 (dd, J = 11.4 and 6.6 Hz, 1H), 4.24 (dd, J = 11.4 
and 8.7 Hz, 1H), 4.51 (br s, 1H); IR (neat) 2944, 1748, 1655, 1449, 1262, 1049, 841, 770 
cm1; HRMS (EI) m/z Calcd for C10H17NO4 (M
+): 215.1157. Found: 215.1146. 
 
5S-Acetoxymethyl-2,3-didehydro-1-methoxy-N-methoxycarbonylpiperidine (4): []28D 
+71.6 (c 1.0, CHCl3); 
1H-NMR (CDCl3)  2.06 (s, 3H), 2.08-2.17 (m, 1H), 2.28-2.46 (m, 1H), 
3.37 and 3.42 (2br s, 3H), 3.77 (s, 3H), 4.09-4.26 (m, 2H), 4.57-4.85 (m, 1H), 5.34-5.61 (m, 
1H), 5.72-5.94 (m, 2H); IR (neat) 2957, 1744, 1709, 1445, 1368, 1231, 1123, 1082, 980, 770 
cm1; HRMS (EI) m/z Calcd for C11H17NO5 (M
+): 243.1107. Found: 243.1090. 
 
5S-Acetoxymethyl-1,2-didehydro-N-methoxycarbonylpiperidine (15): []27D –72.2 (c 1.2, 
methanol); 1H-NMR (CDCl3)  1.69-2.07 (m, 4H), 2.06 (s, 3H), 3.77 (s, 3H), 4.01 (dd, J = 
10.8 and 7.2 Hz, 1H), 4.06-4.22 (m, 1H), 4.45-4.70 (m, 1H), 4.82-5.02 (m, 1H), 6.71 and 6.85 
(2d, J = 8.7 and 9.0 Hz, 1H); IR (neat) 2965, 1742, 1712, 1660, 1448, 1362, 1240 cm1; Anal. 
Calcd for C10H15NO4: C, 56.33; H, 7.09; N, 6.57. Found: C, 56.07; H, 7.17; N, 6.40. 
 
2S,6-Bis(methoxycarbonylamino)hexyl acetate (13): []28D +17.1 (c 1.0, methanol); mp 
97-98 oC; 1H-NMR (CDCl3)  1.35-1.60 (m, 6H), 2.07 (s, 3H), 3.10-3.26 (m, 2H), 3.66 (s, 
3H), 3.67 (s, 3H), 3.82-3.93 (m, 1H), 4.04-4.12 (m, 2H), 4.64-4.84 (m, 2H); IR (KBr) 3335, 
2980, 1755, 1700, 1555, 1230, 1068 cm1; Anal. Calcd for C12H22N2O6: C, 49.65; H, 7.64; N, 
9.65. Found: C, 49.38; H, 7.79; N, 9.90. 
 
Preparation of optically active bicyclic compound 19 
Compound 19 was prepared from L-lysine derivative 2212a or L-pipecolic acid derivative 16 
by procedures similar to preparation of 4. 
The characterization data for compounds 16, 17, 18,15 19,15 and 22 are described below. 
 
5S,N-Bis(methoxycarbonyl)piperidine (16): []25D –60.9 (c 1.5, methanol); 1H-NMR 
(CDCl3)  1.16-1.52 (m, 2H), 1.58-1.75 (m, 3H), 2.16-2.30 (m, 1H), 2.88-3.11 (m, 1H), 3.73 
(s, 3H), 3.74 (s, 3H), 3.92-4.19 (m, 1H), 4.75-4.99 (m, 1H); IR (neat) 2950, 1750, 1710, 1450, 
1265, 1210, 1170, 1095 cm1; Anal. Calcd for C9H15NO4: C, 53.72; H, 7.51; N, 6.96. Found: 
C, 53.70; H, 7.74; N, 6.67. 
 
1,2-Didehydro-5S,N-bis(methoxycarbonyl)piperidine (17): []27D –46.9 (c 1.0, CHCl3); 
1H-NMR (CDCl3)  1.83-2.05 (m, 3H), 2.30-2.42 (m, 1H), 3.74 (s, 3H), 3.75 and 3.80 (2s, 2H 
and 1H), 4.81-4.91 (m, 1H), 4.93-5.02 (m, 1H), 6.81 and 6.94 (2d, J = 9.0 and 8.7 Hz, 2/3H 
and 1/3H); IR (neat) 2950, 1755, 1720, 1445, 1360 cm1; Anal. Calcd for C9H13NO4: C, 
54.26; H, 6.58; N, 7.03. Found: C, 54.17; H, 6.73; N, 6.74. 
 
(6S)-1-Aza-2,3-didehydro-8-oxabicyclo[4.3.0]nonan-9-one (18): []28D +164.9 (c 1.0, 
CHCl3); mp 45-46 
oC; 1H-NMR (CDCl3)  1.50-1.80 (m, 1H), 2.05-2.32 (m, 3H), 3.95-4.15 
(m, 2H), 4.50-4.70 (m, 1H), 5.03-5.15 (m, 1H), 6.60 (d, J = 10.0 Hz, 1H); IR (KBr) 1752, 
1720, 1445, 1360 cm-1; Anal. Calcd for C7H9NO2: C, 60.43; H, 6.51; N, 10.07. Found: C, 
60.16; H, 6.56; N, 9.90. 
 
(6S)-1-Aza-3,4-didehydro-2-methoxy-8-oxabicyclo[4.3.0]nonan-9-one (19): []28D –226.6 
(c 1.0, CHCl3); mp 34-36
oC; 1H-NMR (CDCl3)  2.09-2.35 (m, 2H), 3.45 (s, 3H), 3.92-4.04 
(m, 1H), 4.09 (dd, J = 8.7 and 3.6 Hz, 1H), 4.56 (t, J = 8.4 Hz, 1H), 5.14 (d, J = 1.2 Hz, 1H), 
5.81-5.91 (m, 1H), 5.94-6.02 (m, 1H); IR (KBr) 2982, 1767, 1414, 982, 763 cm1; HRMS 
(EI) m/z Calcd for C8H11NO3 (M
+): 169.0739. Found: 169.0731. 
 
Methyl 2S,6-Bis(methoxycarbonylamino)hexanoate (22): []28D +16.5 (c 1.0, CHCl3); mp 
50-51 oC (uncorrected); 1H-NMR (CDCl3)  1.27-1.44 (m, 2H), 1.46-1.59 (m, 2H), 1.62-1.76 
(m, 1H), 1.78-1.90 (m, 1H), 3.15-3.20 (m, 2H), 3.66 (s, 3H), 3.69 (s, 3H), 3.74 (s, 3H), 
4.31-4.39 (m, 1H), 4.77 (br s, 1H), 5.31 (br s, 1H); IR (KBr) 3290, 2950, 1730, 1695, 1550, 
1275 cm1; Anal. Calcd for C11H20N2O6: C, 47.82; H, 7.30; N, 10.14. Found: C, 48.05; H, 
7.40; N, 10.27. 
 
Preparation of racemic 3-acetoxy-1,2-didehydro-N-methoxycarbonylpiperidine 23, and 
optically active 3-acetoxy-1,2-didehydro-N-acylpiperidines 24 and 25 
Compounds 10a, 4, and 19 were easily transformed into 3-acetoxylated derivative 23, 24 
and 25 by stirring in acetic acid for a few minutes with quantitative yield. 
 
3-Acetoxy-1,2-didehydro-N-methoxycarbonylpiperidine (23) : 1H-NMR (CDCl3)  
1.83-2.03 (m, 2H), 2.05 (s, 3H), 3.30-3.45 (m, 1H), 3.79 (s, 3H), 3.87-4.10 (m, 1H), 4.97-5.15 
(m, 1H), 5.17-5.25 (m, 1H), 6.97 and 7.11 (2br d, J = 9.2 Hz, 1H); IR (neat) 2957, 1717, 1648, 
1447, 1364, 1235, 1007, 768 cm1; HRMS (M





1H-NMR (CDCl3)  1.93-2.23 (m, 1H), 2.02 (s, 3H), 2.05 (s, 3H), 2.18-2.30 (m, 1H), 3.80 (s, 
3H), 4.15-4.31 (m, 2H), 4.53-4.78 (m, 1H), 5.02-5.24 (m, 2H), 6.95 and 7.09 (2d, J = 7.0 and 
6.4 Hz, 1H); IR (neat) 2959, 1752, 1648, 1447, 1334, 1073, 768 cm1; HRMS (EI) m/z Calcd 
for C12H17NO6 (M
+): 271.1056. Found: 271.1066. 
 
(4R,6S)-1-Aza-4-acetoxy-2,3-didehydro-8-oxabicyclo[4.3.0]nonan-9-one (25): mp 77-79 
oC; 1H-NMR (CDCl3)  1.72 (td, J = 12.8 and 3.8 Hz, 1H), 2.06 (s, 3H), 2.24 (d, J = 12.8 Hz, 
1H), 4.01 (t, J = 9.0 Hz, 1H), 4.07-4.21 (m, 1H), 4.67 (t, J = 8.1 Hz, 1H), 5.25-5.33 (m, 2H), 
6.87 (d, J = 6.6 Hz, 1H); IR (KBr) 2905, 1784, 1644, 1426, 1269, 1055, 992, 756 cm1; 
HRMS m/z Calcd for C9H11NO4 (M
+): 197.0689. Found: 197.0668. 
 
Electrochemical acetoxylation of 2,3-didehydro- and 1,2-didehydropiperidine derivatives 
10a-d, 4, 19 and 23 
A typical procedure is exemplified by the anodic oxidation of 4. Into a glass beaker (15 
mL) equipped with two Pt plate electrodes (10 mm x 20 mm) was added a solution of 4 
(0.243g, 1mmol) and AcOK (1.00 g, 10 mmol) in acetic acid (10 mL). After 15 F/mol of 
electricity was passed at a constant current of 0.1A (4 h, terminal voltage: ca 15 V) through 
the solution cooled with water, saturated aqueous NaHCO3 (20 mL) was added into the 
reaction mixture. The organic portion was extracted with AcOEt (20 mL x 3) and the 
combined organic layer was washed with saturated aqueous NaHCO3 (20 mL). After the 
extract was dried over MgSO4 and the solvent was removed in vacuo, the residue was 
chromatographed on silica gel (AcOEt:n-hexane = 1:3) to afford 1,2,3-triacetoxy-5S-acetoxy-
methyl-N-methoxycarbonylpiperidine (5) in 85% yield. 
5: 1H-NMR (CDCl3)  1.91-2.24 (m, 14H), 3.69-3.82 (m, 3H), 4.03-4.39 (m, 2H), 4.45-4.60 
(m, 1H), 4.88-5.07 (m, 1H), 5.15-5.38 (m, 1H), 6.64-6.90 (m, 1H); IR (neat) 2952, 1755, 1597, 
1447, 1372, 1240, 1044, 776 cm1; HRMS (EI) m/z Calcd for C14H19NO8 (M
+AcOH): 
329.1111. Found: 329.1111. 
 
1,2,3-Triacetoxy-N-methoxycarbonylpiperidine (11a): 1H-NMR (CDCl3)  1.77-2.25 (m, 
11H), 3.08-3.17 (m, 1H), 3.74 and 3.76 (2s, 3H), 3.95-4.14 (m, 1H), 4.82-5.02 and 5.14-5.28 
(2m, 2H), 6.56-6.78 and 6.93-7.08 (2m, 1H); IR (neat) 2980, 1786, 1420, 1375, 1256, 1051, 
764 cm1; Anal. Calcd for C13H19NO8: C, 49.21; H, 6.04; N, 4.41. Found: C, 49.14; H, 6.22; N, 
4.35. 
 
1,2,3-Triacetoxy-N-benzyloxycarbonylpiperidine (11b): 1H-NMR (CDCl3)  1.75-2.24 (m, 
11H), 3.09-3.27 (m, 1H), 3.97-4.26 (m, 1H), 4.95-5.31 (m, 4H), 6.80 and 7.10 (2d, J = 1.0 and 
4.0 Hz, 1H), 7.35 (s, 5H); IR (neat) 2953, 1748, 1717, 1370, 1215, 1053, 698 cm1; HRMS  
(EI) m/z Calcd for C19H23NO8 (M
+): 393.1424. Found: 393.1464. 
 
1,2,3-Triacetoxy-N-formylpiperidine (11c): 1H-NMR (CDCl3)  1.80-2.29 (m, 11H), 
2.81-3.17 (m, 1H), 4.15-4.46 (m, 1H), 4.91-5.08 (m, 1H), 5.22-5.37 (m, 1H), 5.95, 6.04, 6.35 
and 6.43 (4d, J = 0.8, 1.0, 3.0 and 4.0 Hz, 1H), 8.25 and 8.28 (2s, 1H); IR (neat) 3567, 2942, 
1759, 1698, 1433, 1374, 1256, 1053, 704 cm1; HRMS (EI) m/z Calcd for C12H17NO7 (M
+): 
287.1005. Found: 287.0981. 
 
1,2,3-Triacetoxy-N-benzoylpiperidine (11d): 1H-NMR (CDCl3)  1.84-2.38 (m, 11H), 
3.10-3.49 (m, 1H), 4.18-4.59 (m, 1H), 4.92-5.13 (m, 1H), 5.21-5.41 (m, 1H), 6.15-6.44 and 
6.61-6.88 (2m, 1H), 7.24-7.51 (m, 5H); IR (neat) 3063, 2940, 1755, 1659, 1374, 1252, 1057, 
702 cm1; Anal. Calcd for C18H21NO7: C, 59.50; H, 5.83; N, 3.85. Found: C, 59.23; H, 6.23; N, 
3.65. 
 
(3R,4R,6S)-2,3,4-Triacetoxy-1-aza-8-oxabicyclo[4.3.0]nonan-9-one (20): 1H-NMR (CDCl3) 
 1.94 (td, J = 12.0 and 1.8 Hz, 1H), 2.05-2.18 (m, 10H), 4.02 (dd, J = 8.6 and 6.6 Hz, 1H), 
4.20-4.30 (m, 1H), 4.52-4.58 (m, 1H), 5.06-5.10 (m, 2H), 6.31 and 6.59 (2d, J = 1.0 and 1.8 
Hz, 3/4H and 1/4H); IR (neat) 2940, 1782, 1420, 1374, 1285, 1048, 764 cm1; HRMS (EI) m/z 
Calcd for C11H13NO6 (M
+AcOH): 255.0743. Found: 255.0726. 
 
Reduction of 1,2,3-triacetoxy-N-acylpiperidine derivatives 5, 11a-d, and 20 
A typical procedure is exemplified by the reduction of 5. Into a solution of 5 (0.389 g, 1 
mmol) and Et3SiH (0.140 g, 1.2 mmol) in CH2Cl2 (3 mL) was added methanesulfonic acid 
(0.144 g, 1.5 mmol) at 0 oC. After stirring for 10 min, into a mixture of AcOEt (20 mL) and 
saturated aqueous NaHCO3 (20 mL) was poured the reaction mixture. The organic portion 
was extracted with AcOEt (20 mL x 3) and the combined organic layer was washed with 
saturated aqueous NaHCO3 (20 mL). After the extract was dried over MgSO4 and the solvent 
was removed in vacuo, the residue was chromatographed on silica gel (AcOEt:n-hexane = 
1:2) to afford 2,3-diacetoxy-5S-acetoxymethyl-N-methoxycarbonylpiperidine (6) in 62% yield 
as a mixture of stereoisomers. Recrystalization of 6 from AcOEt and n-hexane afforded 
2S,3S,5S-isomer. 
 
62S,3S,5S: []26D +40.0 (c 0.5, CHCl3); mp 102-104˚C; 1H-NMR (CDCl3)  1.77-1.87 (m, 1H), 
2.04 (s, 3H), 2.06 (s, 3H), 2.10 (s, 3H), 2.10-2.23 (m, 1H), 3.34 (d, J = 15.0 Hz, 1H), 3.71 (s, 
3H), 4.13 (dd, J = 11.3 and 5.9 Hz, 1H), 4.23 (d, J = 15.0 Hz, 1H), 4.40 (t, J = 9.7 Hz, 1H), 
4.54-4.70 (m, 1H), 4.76-4.87 (m, 1H), 4.91-4.99 (m, 1H); IR (KBr) 2959, 1750, 1701, 1441, 
1374, 1223,1069, 772 cm1; Anal. Calcd for C14H21NO8: C, 50.75; H, 6.39; N, 4.23. Found: C, 
50.88; H, 6.68; N, 4.26. Major isomer of 6 was detected by HPLC method; YMC-Pack SIL 
(0.46 cmø x 15 cm), n-hexane/ethanol = 10:1, wavelength: 210nm, flow rate: 0.5 mL/min, 
retention time:11.4 min. 
 
2,3-Diacetoxy-N-methoxycarbonylpiperidine (12a): 1H-NMR (CDCl3)  1.86-2.19 (m, 8H), 
3.20-3.50 (m, 2H), 3.70 (s, 3H), 3.77-3.98 (m, 1H), 4.71-4.87 (m, 1H), 4.88-4.98 (m, 1H), 
4.99-5.13 (m, 1H); IR (neat) 2959, 1755, 1471, 1374, 1057, 770 cm1; HRMS m/z Calcd for 
C11H17NO6 (M
+): 259.1055. Found: 259.1042. Diastereomer ratio of 12a was determined by 
HPLC method; YMC-Pack SIL (0.46 cmø x 15 cm), n-hexane/ethanol = 10:1, wavelength: 
210 nm, flow rate: 0.5mL/min, retention time: 8.2 min for trans-isomer, 9.1 min for 
cis-isomer. 
 
2,3-Diacetoxy-N-benzyloxycarbonylpiperidine (12b): 1H-NMR (CDCl3)  1.90-2.12 (m, 
8H), 3.30-4.05 (m , 4H), 4.18-5.12 (m, 4H), 7.35 (s, 5H); IR (neat) 3033, 2942, 1752, 1433, 
1254, 1055, 766, 700 cm1; HRMS m/z Calcd for C17H21NO6 (M
+): 335.1369. Found: 
335.1349. Diastereomer ratio of 12b was determined by HPLC method; YMC-Pack SIL (0.46 
cmø x 15 cm), n-hexane/ethanol = 15:1, wavelength: 210 nm, flow rate: 0.5 mL/min, 
retention time: 9.3 min for trans-isomer, 10.4 min for cis-isomer. 
 
2,3-Diacetoxy-N-formylpiperidine (12c): 1H-NMR (CDCl3)  1.80-2.08 (m, 8H), 3.15-3.75 
and 3.95-4.35 (2m, 4H), 4.75-4.88 and 4.95-5.45 (2m, 2H), 7.95, 7.97, 8.08, and 8.10 (4s, 
1H); IR (neat) 3650, 2940, 1759, 1690, 1439, 1372, 1260, 1046 cm1; HRMS m/z Calcd for 
C10H15NO5 (M
+): 229.0950. Found: 229.0975. Diastereomer ratio of 12c was determined by 
HPLC method; YMC-Pack SIL (0.46 cmø x 15 cm), n-hexane/ethanol = 10:1, wavelength: 
210 nm, flow rate: 0.5 mL/min, retention time: 9.0 min for trans-isomer, 9.7 min for 
cis-isomer. 
 
2,3-Diacetoxy-N-benzoylpiperidine (12d): 1H-NMR (CDCl3)  1.70-2.20 (m, 8H), 3.20-4.40 
(m, 4H), 4.68-5.22 (m, 2H), 7.41 (s, 5H); IR (neat) 2940, 1744, 1640, 1431, 1372, 1248, 706 
cm-1; HRMS m/z Calcd for C16H19NO5 (M
+): 305.1263. Found: 305.1273. Diastereomer ratio 
of 12d was determined by HPLC method; YMC-Pack SIL (0.46 cmø x 15 cm), 
n-hexane/ethanol = 10:1, wavelength: 210 nm, flow rate: 0.5 mL/min, retention time: 25.9 
min for trans-isomer, 29.5 min for cis-isomer. 
 
(3R,4R,6S)-3,4-Diacetoxy-1-aza-8-oxabicyclo[4.3.0]nonan-9-one (21): []26D –75.2 (c 0.6, 
CHCl3); mp 127-129˚C (from AcOEt and n-hexane), (uncorrected);
 1H-NMR (CDCl3)  
1.90-2.05 (m, 2H), 2.09 (s, 3H), 2.13 (s, 3H), 3.33 (dd, J = 15.0 and 2.1 Hz, 1H), 3.92-4.05 (m, 
3H), 4.38-4.48 (m, 1H), 4.80-4.85 (m, 1H), 5.08-5.12 (m, 1H); IR (neat) 2932, 1744, 1422, 
1372, 1221, 1061, 914, 768 cm1; Anal. Calcd for C11H15NO6: C, 51.36; H, 5.88; N, 5.45. 
Found: C, 51.49; H, 6.08; N, 5.44. Major isomer of 21 was detected by HPLC method; 
YMC-Pack SIL (0.46 cmø x 15 cm), n-hexane/ethanol = 5:1, wavelength: 210 nm, flow rate: 
0.5 mL/min, retention time: 18.9 min. 
 
Preparation of 2,3-didehydropiperidine derivative 33. 
Into a round-bottomed flask (25 mL) equipped with a magnetic stirrer and containg 19 
(0.423 g, 2.5 mmol) in acetic acid (10 mL) was added NaBH4 (0.946 g, 10 mmol). The 
reaction vessel was cooled with water. After stirring for 10 min, water (10 mL) was added 
slowly to the reaction solution at 0 oC. The mixture was extracted with AcOEt (20 mL x 3). 
The combined extracts were washed with saturated aqueous NaHCO3 (20 mL). After the 
extracts were dried over anhydrous MgSO4, filtered, and concentrated in vacuo, the residue 
was chromatographed on silica gel (AcOEt:n-hexane = 1:2) to afford 33 in 70% yield.  
 
6S-1-Aza-3,4-didehydro-8-oxabicyclo[4.3.0]nonan-9-one (33): []30D –166.9 (c 1.0, 
CHCl3); 
1H-NMR (CDCl3)  2.11-2.37 (m, 2H), 3.64-3.75 (m, 1H), 3.76-3.89 (m, 1H), 4.03 
(dd, J = 8.7 Hz and 5.7 Hz, 1H), 4.08-4.14 and 4.16-4.21 (2m, 1H), 4.52 (t, J = 8.3 Hz, 1H), 
5.70-5.89 (m, 2H); IR (neat) 2977, 1777, 1457, 1242, 1208, 1078, 961, 764 cm1; HRMS (EI) 
m/z Calcd for C7H9NO2 (M
+): 139.0633, Found: 139.0609. 
 
Osmium oxidation of 2,3-didehydropiperidine derivatives 4, 19, 10a, and 33 and the 
successive acetoxylations. 
A typical procedure is exemplified by the osmium oxidation of 10a. Into a 
round-bottomed flask (25 mL) equipped with a magnetic stirrer was added a solution of 5 
(0.171 g, 1 mmol) and NMO (50% in water, 0.351 g, 1.5 mmol) in acetone (0.5 mL) and H2O 
(2.5 mL). To a stirred solution at room temperature was added osmium tetraoxide (4wt % 
solution in water, 2 drops, 0.01 mmol). After the mixture was stirred overnight at room 
temperature, 10% aqueous Na2S2O3 (5 mL) was added into the reaction mixture. The resulting 
mixture was concentrated under reduced pressure. Pyridine (2 mL) and acetic anhydride (2 
mL) were then added to the residue and the mixture stirred at room temperature for 2 h. The 
mixture was concentrated under reduced pressure. To the residue was added water (10 mL) 
and the organic portion was extracted with AcOEt (20 mL x 3). The combined extracts were 
dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The residue was chromato-
graphed on silica gel (AcOEt:n-hexane = 1:5) to afford 1,2,3-triacetoxy-N-methoxycarbonyl-
piperidine (11a) in 71% yield.  
11a: 1H-NMR (CDCl3)  1.78-1.88 (m, 1H), 1.92-2.05 (m, 1H), 2.01, 2.10 and 2.11 (3s, 9H), 
3.09-3.23 (m, 1H), 3.76 (s, 3H), 4.06-4.29 (m, 1H), 5.18-5.28 (m, 2H), 6.71 (br s, 1H); IR 
(neat) 2959, 1748, 1449, 1372, 1223, 1057, 772 cm1; HRMS (EI) m/z Calcd for C13H19NO8 
(M+): 317.1111. Found: 317.1116. 
 
By similar procedures as above, 4 was converted into a mixture of 2,3-diacetoxy-5S-acetoxy-
methyl-1-methoxy-N-methoxycarbonylpiperidine (29a) and 1,2,3-triacetoxy-5S-acetoxy-
methyl-N-methoxycarbonylpiperidine (29b) was obtained in 77% yield (29a:29b = 0.4:0.6) . 
1H-NMR (CDCl3)  1.85-1.95 (m, 2H), 2.02, 2.03, 2.06, 2.07, 2.096, 2.100, 2.12 (7s, 10.8H), 
3.34 and 3.37 (2s, 1.2H), 3.75 and 3.77 (2s, 3H), 4.07-4.20 (m, 1H), 4.22-4.41 (m, 1H), 
4.54-4.79 (m, 1H), 5.18-5.52 (m, 2H), 5.72-5.84 (m, 0.4H), 6.70-6.90 (m, 0.6H); IR (neat) 
2959, 1744, 1445, 1370, 1225, 1090, 774 cm1. 
 
(3R,4S,6S)-3,4-Diacetoxy-2-methoxy-1-aza-8-oxabicyclo[4.3.0]nonan-9-one (32) (85% 
yield from 19): 1H-NMR (CDCl3)  1.84-2.02 (m, 2H), 2.04 (s, 3H), 2.11 (s, 3H), 3.38 (s, 3H), 
3.98-4.10 (m, 2H), 4.48-4.56 (m, 1H), 5.01 (d, J = 2.4 Hz, 1H), 5.19-5.29 (m, 2H); IR (neat) 
2940, 1771, 1414, 1374, 1238, 1102, 970, 764 cm1; HRMS (EI) m/z Calcd for C12H17NO7  
(M+): 287.1005. Found: 287.1014. 
 
Using similar oxidation procedure, 33 was successively oxidized and acetoxylated to afford a 
mixture of (3S,4R,6S)-3,4-diacetoxy-1-aza-8-oxabicyclo[4.3.0]nonan-9-one (282S,3R,5S) and 
(3R,4S,6S)-isomer (282R,3S,5S) (282S,3R,5S:282R,3S,5S = 76:24) in 80% yield.  
(3S,4R,6S)-3,4-Diacetoxy-1-aza-8-oxabicyclo[4.3.0]nonan-9-one (282S,3R,5S): []28D –53.3 
(c 1.5, CHCl3), (containing 4% of (3R,4S,6S)-isomer 282S,3R,5S);
 1H-NMR (CDCl3)  1.70-1.83 
(m, 1H), 2.03 (s, 3H), 2.07-2.13 (m, 1H), 2.14 (s, 3H), 3.22 (t, J = 12.0 Hz, 1H), 3.89-4.09 (m, 
3H), 4.46 (t, J = 9.3 Hz, 1H), 4.80-4.90 (m, 1H), 5.50 (br s, 1H); IR (neat) 2940, 1781, 1485, 




Reduction of -alkoxyl group of 11a, 29a, 29b and 32. 
A typical procedure is exemplified by the reduction of 11a. To 1 mmol of 11a was added 
Et3SiH (0.174 g, 1.5 mmol) in CH2Cl2 (3 mL), methanesulfonic acid (0. 192 g, 2.0 mmol) was 
then added at 0 oC. After stirring for 10 min, into a mixture of AcOEt (20 mL) and saturated 
aqueous NaHCO3 (20 mL) was poured the reaction mixture. The organic portion was 
extracted with AcOEt (20 mL x 3) and the combined organic layers were washed with 
saturated aqueous NaHCO3 (20 mL). After the extracts were dried over anhydrous MgSO4, 
filtered, and concentrated in vacuo, the residue was chromatographed on silica gel 
(AcOEt:n-hexane = 1:5) to afford 2,3-diacetoxy-N-methoxycarbonylpiperidine (12a) in 70% 
yield. cis-2,3-Diacetoxy-N-methoxycarbonylpiperidine (12acis): 1H-NMR (CDCl3)  
1.72-1.83 (m, 1H), 1.87-2.02 (m, 1H), 2.07 and 2.08 (2s, 6H), 3.20-3.48 (m, 2H), 3.70 (s, 3H), 
3.87 and 3.91 (2d, J = 6.0 and 6.0 Hz, 2H), 4.98-5.13 (m, 2H); IR (neat) 2959, 1755, 1474, 
1372, 1278, 1057, 770 cm1; HRMS (EI) m/z Calcd for C11H17NO6 (M
+): 259.1056. Found: 
259.1049. 
 
2S,3R-Diacetoxy-5S-acetoxymethyl-N-methoxycarbonylpiperidine (272S,3R,5S) (70% yield 
from a mixture of 29a and 29b): []30D +37.0 (c 1.0, CHCl3); 1H-NMR (CDCl3)  1.75 and 
1.78 (2d, J=4.4Hz, 1H), 2.02 and 2.07 and 2.08 (3s, 9H), 2.09-2.11 (m, 1H), 3.19 (d, J = 15.0 
Hz, 1H), 3.72 (s, 3H), 4.10 and 4.15 (2d, J = 5.7 Hz, 1H), 4.23-4.38 (m, 2H),  4.69-4.82 (br s, 
1H), 5.03-5.13 (m, 1H), 5.19 (br s, 1H); IR (neat) 2959, 1755, 1709, 1451, 1374, 1256, 1055, 
770 cm1; HRMS m/z Calcd for C14H21NO8 (M
+): 331.1267. Found: 331.1258. Major isomer 
of 27 was detected by HPLC method; YMC-Pack SIL (0.46 cmø x 15 cm), n-hexane/ethanol 
= 10:1, wavelength: 210 nm, flow rate: 0.5 mL/min, retention time: 12.2 min. 
 
(3R,4S,6S)-3,4-Diacetoxy-1-aza-8-oxabicyclo[4.3.0]nonan-9-one (282R,3S,5S) (81% yield 
from 32): []29D –48.0 (c 0.5, CHCl3); mp 122-123˚C (from AcOEt and n-hexane), 
(uncorrected); 1H-NMR (CDCl3)  1.89-1.99 (m, 2H), 2.05 (s, 3H), 2.11 (s, 3H), 3.13 (dd, J = 
12.8 and 1.8 Hz, 1H), 3.84-3.95 (m, 1H), 4.04 (dd, J = 8.4 and 3.3 Hz, 1H), 4.10 (d, J = 12.5 
Hz, 1H), 4.44 (t, J = 7.8 Hz, 1H), 4.92-5.03 (m, 1H), 5.19 (br s, 1H); IR (KBr) 2936, 1763, 
1431, 1374, 1258, 1073, 986, 764 cm1; Anal. Calcd for C11H15NO6: C, 51.36; H, 5.88; N, 
5.45. Found: C, 51.43; H, 5.93; N, 5.40. Major isomer of 11 was detected by HPLC method; 
YMC-Pack SIL (0.46 cmø x 15 cm), n-hexane/ethanol = 5:1, wavelength: 210nm, flow rate: 
0.5 mL/min, retention time: 21.6 min.  
 
Synthesis of 5S-acetoxymethyl-2S,3R-dihydroxy-N-methoxycarbonylpiperidine 
(302S,3R,5S) and successive tosylation.  
Into a round-bottomed flask (25 mL) equipped with a magnetic stirrer and containing a 
solution of 4 (0.243 g, 1 mmol) in acetone (0.5 mL) and H2O (2.5 mL) was added NMO (50% 
in water, 0.351 g, 1.5 mmol). To a stirred solution at room temperature was added osmium 
tetraoxide (4wt % solution in water, 2drops, 0.01 mmol). After the mixture was stirred 
overnight at room temperature, 10% aqueous Na2S2O3 (5 mL) was added into the reaction 
mixture. The resulting mixture was concentrated under reduced pressure and to the residue 
was added water (1 mL). The organic portion was extracted with AcOEt (15 mL x 8). The 
combined extracts were dried over anhydrous MgSO4, filtered, and concentrated in vacuo to 
afford a crude mixture of mixture of 
5S-acetoxymethyl-1,2,3-trihydroxy-N-methoxycarbonylpiperidine and 5S-acetoxy-
methyl-2,3-dihydroxy-1-methoxy-N-methoxycarbonylpiperidine (0.5:0.5) : 1H-NMR (CDCl3) 
 1.70-1.85 (m, 1H), 1.89-2.04 (m, 1H), 2.06 (s, 3H), 3.33 (s, 1.5H), 3.74 and 3.76 (2s, 3H), 
3.91-4.08 (m, 1H), 4.10-4.20 (m, 1H), 4.21-4.42 (m, 2H), 4.47-4.75 (m, 1H), 5.35-5.44 and 
5.51-5.62 and 5.79-5.84 (3m, 1H); IR (neat) 3413, 2959, 1742, 1449, 1356, 1240, 1086, 774 
cm1. 
 
To the mixture was added Et3SiH (0.174 g, 1.5 mmol) in CH2Cl2 (3 mL) and added 
methanesulfonic acid (0.192 g, 2.0 mmol) at 0 oC. After stirring for 10 min, into a mixture of 
AcOEt (20 mL) and saturated aqueous NaHCO3 (20 mL) was poured the reaction mixture. 
The organic portion was extracted with AcOEt (20 mL x 3) and the combined organic layers 
were washed with saturated aqueous NaHCO3 (20 mL). After the extracts were dried over 
anhydrous MgSO4, filtered, and concentrated in vacuo, the residue was chromatographed on 
silica gel (AcOEt:n-hexane = 3:1) to afford 5S-acetoxymethyl-2S,3R-dihydroxy-N-methoxy-
carbonylpiperidine (302S,3R,5S) in 78% yield from 4. (302S,3R,5S): []30D 6.0 (c 1.0, CHCl3); 
1H-NMR (CDCl3)  1.73 and 1.77 (2d, J = 4.2 Hz, 1H), 1.91-2.02 (m, 1H), 2.05 (s, 3H), 2.24 
(d, J = 6.5 Hz, 1H), 2.31-2.48 (br s, 1H), 3.10 (d, J = 15.0 Hz, 1H), 3.72 (s, 3H), 3.80-3.96 (m, 
2H), 4.06-4.38 (m, 3H), 4.57-4.73 (br s, 1H); IR (neat) 3447, 2959, 1744, 1698, 1456, 1370, 
1258, 1140, 1080, 770 cm1; HRMS m/z Calcd for C10H17NO6 (M
+): 247.1056. Found: 
247.1058. 
 
To 302S,3R,5S (0.1 g, 0.4 mmol) was added p-toluenesulfonyl chloride (0.381 g, 2 mmol), Et3N 
(0.049 g, 0.48 mmol), and DMAP (0.244 g, 2 mmol) in CH2Cl2 (2 mL). After the mixture was 
stirred for 3 days at room temperature, into a mixture of AcOEt (20 mL) and saturated 
aqueous NaHCO3 (10 mL) was poured the reaction mixture. The organic portion was 
extracted with AcOEt (20 mL x 3). After the extracts were dried over anhydrous MgSO4, 
filtered, and concentrated in vacuo, the residue was chromatographed on silica gel 
(AcOEt:n-hexane = 1:6) to afford 
5S-acetoxymethyl-2S,3R-bis(p-toluenesulfonyloxy)-N-methoxycarbonylpiperidine (312S,3R,5S) 
in 46% yield. 
312S,3R,5S: []30D +32.4 (c 1.0, CHCl3); mp 136-139˚C (from AcOEt and n-hexane);  1H-NMR 
(CDCl3)  1.64 and 1.71 (2d, J = 3.6 Hz, 1H), 2.01 (s, 3H), 2.10-2.26 (m, 1H), 2.46 (s, 6H), 
3.09 (d, J = 15.3 Hz, 1H), 3.69 (s, 3H), 3.97-4.16 (m, 2H ), 4.45 (d, J = 15.3 Hz, 1H), 
4.55-4.72 (m, 3H), 7.30-7.39 (m, 4H), 7.64 (d, J = 8.1 Hz, 2H), 7.79 (d, J = 8.4 Hz, 2H); IR 
(KBr) 2957, 1748, 1701, 1449, 1364, 1246, 1140, 1124, 918, 770 cm1; Anal. Calcd for 
C24H29NO10S2: C, 51.88; H, 5.26; N, 2.52. Found: C, 51.92; H, 5.39; N, 2.52.  
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